FDA Approved: ZORYVE — Original Application (Arcutis Biotherapeutics, Inc.)

View source ↗

Summary

The FDA approved ZORYVE (roflumilast) under an original application for topical treatment of plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ZORYVE (ROFLUMILAST)

Snippet

ORIG AP for ZORYVE (ROFLUMILAST)